BCWM LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-22,955
Closed -$3.2M 76
2015
Q4
$3.2M Buy
22,955
+386
+2% +$53.2K 1.93% 16
2015
Q3
$3.16M Buy
22,569
+2,544
+13% +$382K 1.55% 22
2015
Q2
$3.29M Sell
20,025
-3,593
-15% -$574K 1.38% 27
2015
Q1
$36.5M Sell
23,618
-13,418
-36% -$1.91M 1.69% 22
2014
Q4
$46.5M Buy
37,036
+529
+1% +$65.4K 2.25% 9
2014
Q3
$43.7K Sell
36,507
-14,991
-29% -$1.72M 2.19% 10
2014
Q2
$5.54M Sell
51,498
-302
-0.6% -$31.1K 2.82% 3
2014
Q1
$5.16M Buy
51,800
+1,911
+4% +$173K 2.72% 4
2013
Q4
$4.61M Sell
49,889
-364
-0.7% -$32.3K 2.61% 4
2013
Q3
$4.2M Sell
50,253
-9,703
-16% -$832K 2.57% 5
2013
Q2
$4.91M Buy
+59,956
New +$4.49M 2.98% 2

Other funds holding ELV

BCWM LLC's ELV Position: Q1 2016 in Review

BCWM LLC sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 22,955 shares — an estimated $3.2M sold.

BCWM LLC first reported a position in ELV in Q2 2013 and held it in 11 quarters. The position peaked at $46.5M in Q4 2014. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • BCWM LLC reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
  • BCWM LLC sold 22,955 Elevance Health shares in Q1 2016, an estimated $3.2M.
  • BCWM LLC first reported a position in Elevance Health in Q2 2013 and held it in 11 quarters.
  • BCWM LLC's Elevance Health position peaked at $46.5M in Q4 2014.
  • 771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on BCWM LLC's 13F filing for Q1 2016, filed 12 May 2016.